# Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

> **NCT01880515** · PHASE2 · COMPLETED · sponsor: **Instituto Nacional de Cancerologia de Mexico** · enrollment: 107 (actual)

## Conditions studied

- Skin Rash
- Lung Cancer

## Interventions

- **DRUG:** Tetracycline

## Key facts

- **NCT ID:** NCT01880515
- **Lead sponsor:** Instituto Nacional de Cancerologia de Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2014-07
- **Final completion:** 2014-11
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01880515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01880515, "Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01880515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*